Shanghai Pharmaceuticals said a subsidiary, Beijing Keyuan Xinhai Pharma, signed a strategic agreement with Guangdong Province’s Center for Disease Control and Prevention. The two entities will set up a joint institute to research cold chain technology in the distribution of biological products, especially vaccines. More details.... Stock Symbols: (SHA: 601607; HK: 02607) Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});